WRAP Research News
The newest WRAP Update is available now.
Save the date for an upcoming Info Session near you
On September 27, pharmaceutical companies Eisai and Biogen released a statement describing results from an experimental drug, lecanemab, that showed a potential reduction of clinical decline in a study of people with early Alzheimer’s disease. …
Staff members from WRAP and Brain biomarker lab were able to meet together for an all staff retreat in late September. The day was a day for organizational planning, connecting and important conversations about how …
- More research news from WRAP
Thank you to the wonderful research participants who have made 20 years of WRAP possible. Principal Investigator Sterling Johnson, PhD, shares research highlights and exciting next steps for the study: